person
Kamila P.
- Country
- Poland
- Department
- -
Research Overview
assignment
23
Clinical Trials ·
- Phase I/II Randomized Placebo‑Controlled Dose‑Finding Study of Intramuscular MRT1800 mRNA Vaccine (Combination Therapy) in Adults 18–45 Years with Moderate‑to‑Severe Acne
- Evaluation of Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Amlitelimab in Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
- Phase 3 Study on the Safety and Efficacy of Upadacitinib Versus Dupilumab in Pediatric Patients Aged 2-12 with Moderate to Severe Atopic Dermatitis
location_city
2
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
229
Sites with multiple studies
Has run more than one trial at 229 of 442 partner sites.
Specializations
Inflammatory Skin Conditions
The investigator specializes in treating various forms of moderate-to-severe plaque psoriasis, conducting extensive research into novel therapeutic approaches for this chronic skin condition.
- Oral therapeutic agents
- Long-term safety evaluations
- Treatment tolerability assessment
Atopic Dermatitis Management
Expertise in treating moderate to severe atopic dermatitis with particular focus on biological therapies and innovative treatment approaches for both adult and pediatric populations.
- Biologic therapy assessment
- Long-term treatment efficacy
- Pediatric dermatology applications
Specialized Dermatological Conditions
Active research in treating complex dermatological conditions including prurigo nodularis, chronic pruritus, and discoid lupus erythematosus.
- Novel therapeutic compounds
- Itch management protocols
- Autoimmune skin disorders
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.